279 related articles for article (PubMed ID: 30550831)
1. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
Machirori M; Patch C; Metcalfe A
Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
[TBL] [Abstract][Full Text] [Related]
2. Reproductive decision-making in young female carriers of a BRCA mutation.
Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
[TBL] [Abstract][Full Text] [Related]
3. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
4. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
Adams I; Christopher J; Williams KP; Sheppard VB
J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
[TBL] [Abstract][Full Text] [Related]
6. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
Sheppard VB; Mays D; LaVeist T; Tercyak KP
J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
[TBL] [Abstract][Full Text] [Related]
7. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
[TBL] [Abstract][Full Text] [Related]
8. Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.
McKinnon W; Naud S; Ashikaga T; Colletti R; Wood M
J Genet Couns; 2007 Aug; 16(4):433-56. PubMed ID: 17594133
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
Lehmann LS; Weeks JC; Klar N; Garber JE
Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
[TBL] [Abstract][Full Text] [Related]
10. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Armstrong K; Micco E; Carney A; Stopfer J; Putt M
JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
[TBL] [Abstract][Full Text] [Related]
12. Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
Ray JA; Loescher LJ; Brewer M
J Genet Couns; 2005 Dec; 14(6):473-84. PubMed ID: 16388328
[TBL] [Abstract][Full Text] [Related]
13. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA
J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
Johns D; Agarwal J; Anderson L; Ying J; Kohlmann W
J Womens Health (Larchmt); 2017 Jun; 26(6):702-706. PubMed ID: 27922795
[TBL] [Abstract][Full Text] [Related]
15. Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London.
Kohut K; D'Mello L; Bancroft EK; Thomas S; Young MA; Myhill K; Shanley S; Briggs BH; Newman M; Saraf IM; Cox P; Scambler S; Wagman L; Wyndham MT; Eeles RA; Ferris M
Fam Cancer; 2012 Mar; 11(1):107-13. PubMed ID: 22016143
[TBL] [Abstract][Full Text] [Related]
16. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
17. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
Culver JO; Brinkerhoff CD; Clague J; Yang K; Singh KE; Sand SR; Weitzel JN
Clin Genet; 2013 Nov; 84(5):464-72. PubMed ID: 23323793
[TBL] [Abstract][Full Text] [Related]
18. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
Kautz-Freimuth S; Redaèlli M; Shukri A; Kentenich H; Simic D; Mildenberger V; Schmutzler R; Rhiem K; Stock S
BMC Med Inform Decis Mak; 2023 Oct; 23(1):223. PubMed ID: 37845719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
